Inclusion Criteria:  Adult patients (≥18 years of age) diagnosed with AML who are going to undergo stem cell transplant (SCT). These subjects must provide written informed consent to participate. Subjects must have an identified mutation that has been validated on the multiplex daPCR assay.  Exclusion Criteria:  Adult patients (≥18 years of age) diagnosed with AML who are scheduled to undergo SCT at the NCCH who do not provide written informed consent to participate are ineligible.